top TOP
August 31, 2022

Osnat Ashur-Fabian, PhD

Meir Medical Center

ICRF Project Grant Recipient

Osnat Ashur-Fabian, PhD, of Meir Medical Center, recipient of an ICRF Project Grant, is studying drug resistance in ovarian carcinoma, a cancer that ranks fifth in incidence in women. In order to improve treatment outcomes, she believes that a deeper understanding of resistance mechanisms is urgently needed. An enzyme called DIO3 was shown to be involved in ovarian cancer growth. Dr. Ashur-Fabian aims to study the potential role played by this enzyme in ovarian cancer treatment resistance, as well as the impact of inhibiting this enzyme as a novel approach for sensitizing cells to drugs.

View Grant Recipient profile

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: